Rankings/COVID Intel - by William Makis (McGill Medicine)
COVID Intel - by William Makis (McGill Medicine)
by William Makis
INTEL on COVID-19, mRNA Vaccines, Turbo Cancer, Cancer Treatments, Ivermectin, Fenbendazole, Vaccine injuries and much more. Content is for informational purposes only. None of the information constitutes medical advice (please see your doctor as needed)
Free subscribers
~146k
Est. revenue
$610k – $1.1M / yr
Last 30 days
Strong growth
Public estimates are rounded ranges, not exact figures. Paid plans include precise metrics, history charts, sponsor intel, and exports. Last updated Jul 27, 2026.
Free Substats Weekly
Every Friday: breakout publications, revenue milestones, and what moved in the Substack economy. No account required.
Want the full dataset? View paid plans.
Want the full picture on COVID Intel - by William Makis (McGill Medicine)?
Upgrade for subscriber history charts, sponsor details, cross-publication search, exports, and alerts. Public pages show rounded estimates only.